A
Adaptimmune - ADR (ADAP)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Adaptimmune - ADR (ADAP)
Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company. The Company is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor (SPEAR) T-cell platform. Its SPEAR T-cell platform enables it... Read more
- USD0.31
- USD0.31
- USD0.30
- USD1.48
- 17.00%
- 139M
- 310.42k
- 821.41k
- 75M
- 0.20
- -72.70%
Stock News
5 hours ago
Alphabet: Waymo's Importance Is Growing
SeekingAlpha
5 hours ago
May FOMC Meeting: Waiting For More Clarity
SeekingAlpha
5 hours ago
Altice USA, Inc. 2025 Q1 - Results - Earnings Call Presentation
SeekingAlpha
yesterday
The U.S. economy might be able to handle any disruption from Trump’s tariffs more easily than Wall Street expects
MarketWatch
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
